Published June 8, 2016 This content is archived.
Edward Bednarczyk, department chair and clinical associate professor, pharmacy practice, was elected president of the American Pharmacists Association-Academy of Pharmaceutical Research and Science (APhA-APRS) for the 2017-18 term.
Bednarczyk received his BS in pharmacy from UB in 1984, and completed a pharmacy practice residency at the Buffalo General Hospital in 1985. He went on to receive his PharmD degree from the Medical University of South Carolina followed by a fellowship in Clinical Cardiovascular Pharmacology at Case Western Reserve University/University Hospitals of Cleveland. He came to the University at Buffalo in 1993 through the Clinical Pharmacokinetics Lab and the Department of Nuclear Medicine within the School of Medicine. He switched his primary appointment to the School of Pharmacy and Pharmaceutical Sciences in 1998. He was named chair of the Department of Pharmacy Practice in 2007. His research is largely focused on the use of molecular imaging to explore drug effects, with his clinical responsibilities divided between nuclear medicine and neurology.
The APhA-Academy of Pharmaceutical Research and Science (APhA-APRS) stimulates the discovery, dissemination and application of research to improve patient health and serves pharmacists and those members who are involved in the pharmaceutical sciences. Members of APhA may choose to belong to a primary section within APhA-APRS based on their area of research. APhA-APRS is governed by an Executive Council comprised of elected leaders from the three Sections of APhA-APRS: Basic Sciences, Clinical Sciences and Economic, Social and Administrative Sciences. Members receive access to continuing education, an online community for pharmacists, networking and leadership opportunities, premier research journals such as JAPhA and JPharmSci, cutting edge information on Medication Therapy Management, and regulatory issues facing the profession.